This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1093/JAC/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q84596227
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в липні 2011 scientific article published on 25 July 2011 artículu científicu espublizáu en xunetu de 2011
p:P577
wds:Q84596227-6DB8618C-E703-46F0-A3D2-E3BD9647535E
wdt:P577
2011-07-25T00:00:00Z
p:P2093
wds:Q84596227-B50FAEBE-998D-4ED4-8DAF-DBFAA87127A8 wds:Q84596227-62340A80-BC00-4259-9EF6-98AAEF1A2955 wds:Q84596227-4E2E2F1A-5204-4613-BA05-68297E84F9FD wds:Q84596227-5AB53633-86FF-47EA-B4EA-9FE335FA4AD0 wds:Q84596227-30028428-8B33-496A-8A32-DB86366BFC35 wds:Q84596227-F565F168-EA57-4D27-A1FB-B5E36A55B607
wdt:P2093
Paul Whitaker Rachel Metcalfe Daniel G Peckham Steven P Conway Ian J Clifton Maria Phillip
rdfs:label
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis Pharmacokinetics of oral voriconazole in patients with cystic fibrosis
skos:prefLabel
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis Pharmacokinetics of oral voriconazole in patients with cystic fibrosis
schema:name
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis Pharmacokinetics of oral voriconazole in patients with cystic fibrosis
p:P50
wds:Q84596227-E9555574-A914-44DF-B519-9565E69A6162
wdt:P50
wd:Q61839783
p:P1476
wds:Q84596227-3F1970B2-E875-489F-8548-3E0DEC81244F
wdt:P1476
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis
p:P304
wds:Q84596227-038E0FB8-3A31-4AA1-A1A6-3A123D3DFA90
wdt:P304
2438-2440
p:P31
wds:Q84596227-CBCF3157-1C48-4CEA-8852-47993B6A7FE2
wdt:P31
wd:Q13442814
p:P921
wds:Q84596227-38E979A4-85B7-4957-A47F-C98BDFF45F28 wds:Q84596227-067281B1-2B20-40BB-97F7-F106A71A2994
wdt:P921
wd:Q178194 wd:Q412236
p:P698
wds:Q84596227-46DBFA23-DA69-4009-ADF6-6476F90EE47B
wdtn:P698
n10:21791443
wdt:P698
21791443
p:P1433
wds:Q84596227-DBCE2353-BA7B-4625-B9DE-84433E16392F
wdt:P1433
wd:Q6294770
p:P433
wds:Q84596227-A259A41A-346F-4985-8C64-51130FD7EF59
p:P478
wds:Q84596227-C9FF81BE-A068-499F-92F3-1E5E3F5FA8D8
wdt:P433
10
wdt:P478
66
p:P356
wds:Q84596227-08790325-890D-45A1-ABDC-0BADBEBFEDB9
wdtn:P356
n9:DKR300
wdt:P356
10.1093/JAC/DKR300